drugbank_id,ref_id,title,url
DB00016,,"EMA Summary of Product Characteristics: RETACRIT (epoetin alfa-epox) injection, for intravenous or subcutaneous use",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/085/original/WC500054377.pdf?1526579130
DB00016,,Epoetin Alfa (Epogen®) Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/086/original/EpoetinAlfaMonograph.doc?1526580354
DB00062,,Albuminex package insert,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/229/original/Package_Insert-albuminex-5-clean.pdf?1529615466
DB00062,,Albuminex 25 package insert,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/230/original/Package_Insert_albuminex-25-clean.pdf?1529616277
DB00062,,CSL Bhering Prescribing Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/231/original/AlbuRx5-Prescribing-Information.pdf?1529616518
DB00072,,Trastuzumab: Antineoplastic agent; a recombinant DNA- derived humanized anti-HER2 monoclonal antibody (complete heavy chain sequence),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/202/original/1-10-113.pdf?1529534749
DB00091,,NEORAL (cyclosporine) HC label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/091/original/1.pdf?1548282055
DB00115,,"Cyanocobalamin VitB12, MSDS",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/733/original/Cyanocobalamin_VitB12_MSDS.pdf?1551370759
DB00115,,"Cyanocobalamin injection, monograph",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/736/original/Monograph__cyanocobalamin_injection.pdf?1551377858
DB00115,,Cyanocobalamin label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/739/original/Cyanocobalamin_label__FA_Davis.pdf?1551384561
DB00169,,Cholecalciferol Canadian Prescribing Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/027/original/LUXA-D-product-monograph.pdf?1553031970
DB00169,,Decalcitrol (coated cholecalciferol tablet) US FDA Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/042/original/20171228_c5475e39-3d34-40f9-abf9-cb1af73c4c6c.pdf?1553115210
DB00169,,CLH Report for Cholecalciferol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/048/original/clh_report_colecalciferol_en.pdf?1553119499
DB00169,,Alendronate sodium and cholecalciferol Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/051/original/Alendronate-Cholecalciferol_TAB_Monograph.pdf?1553120651
DB00175,,PRAVACHOL (pravastatin) monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/603/original/1.pdf?1556750204
DB00177,,"NZ Data Sheet, Valsartan and sacubitril",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/136/original/NZ_Data_sheet__Valsartan_and_sacubitril.pdf?1548434596
DB00177,,Valsartan and Sacubitril FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/142/original/Valsartan_and_Sacubitril_FDA_label.pdf?1548436930
DB00177,,Valsartan and Amlodipine FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/145/original/Exforge_FDA_label.pdf?1548437682
DB00177,,Valsartan and Nevibolol FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/148/original/Nevibolol_and_Valsartan.pdf?1548438575
DB00177,,Health Canada Monograph - Valsartan,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/703/original/Health_Canada_Monograph_-_Valsartan.PDF?1568224670
DB00182,,EZETROL (amphetamine) Canadian label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/244/original/1.pdf?1548883785
DB00191,,QSYMIA (phentermine/topiramate) FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/283/original/fda.pdf?1549057509
DB00193,,Health Canada Monograph - Tramadol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/679/original/Health_Canada_Monograph_-_Tramadol.PDF?1565204435
DB00198,,Oseltamivir FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/094/original/209113Orig1s000lbl.pdf?1548284241
DB00198,,Oseltamivir EMA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/097/original/tamiflu-epar-product-information_en.pdf?1548284404
DB00198,,Oseltamivir New Zealand Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/115/original/Tamiflucapsusp.pdf?1548355321
DB00199,,Erythromycin estolate monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/343/original/Erythromycin_Estolate.pdf?1549406070
DB00203,,Revatio (sildenafil) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/850/original/021845s011_022473s004_0203109s002lbl-2.pdf?1552000083
DB00203,,Viagra (sildenafil citrate) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/853/original/20895s039s042lbl.pdf?1552000164
DB00203,,"Viagra (sildenafil citrate) Tablets 25 mg, 50 mg, and 100 mg Canadian Product Monograph",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/856/original/VIAGRA_PM_E_218856_18Sept2018a.pdf?1552000421
DB00203,,Revatio (sildenafil citrate) Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/859/original/REVATIO_PM_E_206732_30Oct2017.pdf?1552000572
DB00203,,Revatio (sildenafil citrate) EMA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/883/original/revatio-epar-product-information_en.pdf?1552079582
DB00203,,Viagra (sildenafil citrate) EMA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/886/original/viagra-epar-product-information_en.pdf?1552080070
DB00207,,Zithromax FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/154/original/zithromax_fda.pdf?1548452062
DB00207,,"Azithromycin, Ophthalmic FDA label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/163/original/Azithromycin__Opthalmic.pdf?1548697689
DB00207,,Sandoz Azithromycin Canadian Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/166/original/Sandoz_Azithromycin_PM_EN.pdf?1548698085
DB00213,,"Pantoprazole Tablets, Monograph",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/193/original/Pantoprazole_tablet_monograph.pdf?1548778232
DB00213,,Pfizer Safety Data Sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/196/original/Pfizer_Data_sheet.pdf?1548779085
DB00213,,"Assessment Report, Pantozol",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/199/original/Assessment_report__pantozol.pdf?1548779471
DB00213,,Protonix delayed release and oral suspension FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/202/original/Protonix_Delayed_relase_and_ora_susp.pdf?1548780962
DB00213,,Pantoloc EMA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/208/original/Pantoloc_EMA_label.pdf?1548797723
DB00213,,Sandoz Pantoprazole DRT Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/217/original/Pantoprazole_DRT_Product_Monograph.pdf?1548867270
DB00213,,Health Canada Label - Pantoprazole,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/486/original/Health_Canada_Label_-_Pantoprazole.PDF?1556054659
DB00213,,TOP Guidelines - H pylori,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/498/original/h_pylori_guideline.pdf?1556058194
DB00215,,Celexa Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/271/original/Celexa_Monograph.pdf?1549042837
DB00227,,FDA Label - Lovastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/661/original/FDA_Label_-_Lovastatin.pdf?1564095428
DB00227,,Health Canada Monograph - Lovastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/664/original/Health_Canada_Monograph_-_Lovastatin.PDF?1564095447
DB00231,,Temazepam Capsules USP 15 mg and 30 mg Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/718/original/00043056.PDF?1551292587
DB00231,,Temazepam Fact Sheet from http://cdn.neiglobal.com/content/pg/live/temazepam.pdf,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/721/original/temazepam.pdf?1551292694
DB00241,,"N-FIORINAL®-C 1/4, 1/2 (acetylsalicylic acid-caffeine-codeine-butalbital) Product Information - Novartis Canada",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/561/original/fiorinal-c_scrip_e.pdf?1556644474
DB00243,,RANEXA (ranolazine) Australian report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/616/original/auspar-ranolazine-180220-pi.docx?1550701302
DB00244,,Pentasa (Mesalazine) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/001/original/020049s025lbl.pdf?1548091158
DB00245,,pdp-BENZTROPINE (benztropine) Prescribing information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/679/original/1.pdf?1551134356
DB00245,,Benztropine informational sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/682/original/1.pdf?1551135890
DB00257,,Canesten Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/088/original/Canesten_Monograph.pdf?1548281505
DB00257,,"MedSafe NZ Data Sheet, Clotrimazole",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/100/original/MedSafe_NZ_Data_Sheet-_Clotrimazole.pdf?1548285796
DB00257,,"HPLC Measurement, Bbod Distribution, and Pharmacokinetics of Oral Clotrimazole, Potentially Useful Antisickling Agent",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/118/original/d2ed21035f3954c34567bfbf5484a60db9e9.pdf?1548355508
DB00257,,Lotrisone FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/121/original/Lotrisone_FDA_label.pdf?1548362277
DB00257,,Clotrimazole SDS,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/124/original/Safety_data_sheet__clotrimazole.pdf?1548367831
DB00268,,Ropinirole extended release FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/382/original/Ropinirole_XL_.pdf?1549488616
DB00268,,"UK labeling, Ropinirole",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/391/original/UK_labeling__Ropinirole.pdf?1549495050
DB00275,,FDA Label - Olmesartan,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/709/original/FDA_Label_-_Olmesartan.pdf?1568842680
DB00275,,Health Canada Monograph - Olmesartan,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/712/original/Health_Canada_Label_-_Olmesartan.PDF?1568842696
DB00281,,"Xylocaine (lidocaine HCl Injection, USP) FDA Label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/349/original/006488s074lbl.pdf?1555019975
DB00281,,"University of Virginia Children's Hospital: Use of Lidocaine for Analgesia in Children and Adolescents, by Marcia L. Buck, Pharm.D., FCCP, FPPAG",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/444/original/201312.pdf?1555966035
DB00281,,Cytochrome P450-mediated drug interactions affecting lidocaine by Mika Isohanni,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/468/original/d52553bb6113e1ea3aa0e5f6597ba2d88669.pdf?1556038452
DB00286,,Pfizer Safety Data Sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/895/original/1.pdf?1552088162
DB00289,,FDA Label - atomoxetine,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/639/original/FDA_Label_-_atomoxetine.pdf?1561418207
DB00300,,Tenofovir Disoproxil FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/406/original/Tenofovir_Disoproxil_FDA_label.pdf?1549561434
DB00300,,Auspar: Tenofovir disoproxil fumarate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/412/original/auspar-tenofovir-disoproxil-fumarate-170601-pi.pdf?1549569936
DB00300,,Stribild FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/418/original/Stribild_FDA_label.pdf?1549580373
DB00300,,Truvada FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/421/original/Truvada_FDA_label.pdf?1549580450
DB00300,,Viread EPAR,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/442/original/viread-epar-product-information_en.pdf?1549651026
DB00304,,MADELINE (desogestrel and ethinyl estradiol) Australian monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/127/original/1.pdf?1553644223
DB00316,,"Acetaminophen monograph, suppository",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/124/original/Acetaminophen_monograph__suppository.pdf?1553636652
DB00316,,"Acetaminophen data sheet, ebi.ac.uk",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/133/original/Data_sheet__Acetaminophen__ebi.ac.uk.pdf?1553705729
DB00316,,"Tylenol arthritis pain label, OTC",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/136/original/Tylenol_arthritis_pain_label.pdf?1553716877
DB00318,,"EPAR, Codeine",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/658/original/EPAR__Codeine.pdf?1551126557
DB00318,,"Codeine, MedSafe NZ document",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/661/original/CodeinePhosphatePSMtab.pdf?1551126735
DB00321,,Elavil Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/454/original/ELAVIL_PM.pdf?1549664331
DB00321,,"Safety data sheet, amitriptyline",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/460/original/Safety_data_sheet__amitriptyline.pdf?1549909752
DB00327,,BAR-hydromorphone monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/181/original/1.pdf?1553996595
DB00331,,Comparing Dissolution Profiles of of Seven Metformin Formulations in Simulated Intestinal Fluid,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/976/original/Comparing_dissolution_profiles.pdf?1533316462
DB00331,,Glumetza FDA,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/977/original/Glumetza.pdf?1533316755
DB00331,,Metformin label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/096/original/Metformin_label.pdf?1553286670
DB00331,,Metformin Canadian monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/099/original/glucophage_Canadian_monograph.pdf?1553287875
DB00331,,MedSafe NZ Metformin mylan,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/102/original/Medsafe_NZ_metformin_myan.pdf?1553289694
DB00333,,FDA Label - Methadone,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/685/original/FDA_Label_-_methadone.pdf?1566927671
DB00333,,Health Canada Label - Metadol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/688/original/Health_Canada_Label_-_Metadol.PDF?1566927686
DB00333,,Health Canada Label - Methadose,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/691/original/Health_Canada_-_Methadose.PDF?1566927906
DB00364,,"Product monograph, Sulcrate",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/519/original/Product_Monograph__Sulcrate.pdf?1556227271
DB00364,,"MedSafe NZ, Sucralfate",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/528/original/MedSafe_NC_sucralfate.pdf?1556552503
DB00364,,"Sucralfate FDA label, tablet form",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/534/original/Sucralfate_tablet_FDA_label.pdf?1556560171
DB00364,,Risk profile of sucralfate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/537/original/Risk_Profile_Sucralfate_03.pdf?1556570730
DB00370,,"Monograph, Mylan mirtazapine",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/597/original/Mylan_mirtazapine.pdf?1556742511
DB00375,,Colestid/Flavored Colestid (colestipol hydrochloride for oral suspension),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/555/original/017563s023_020222s005lbl-3.pdf?1556642803
DB00375,,Pfizer MSDS for Colestipol Hydrochloride for Oral Suspension,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/564/original/COLESTIPOL_HYDROCHLORIDE_FOR_ORAL_SUSPENSION.pdf?1556644523
DB00375,,Colestipol hydrochloride Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/567/original/00022293.PDF?1556647403
DB00381,,"Apo amlodipine tablets, MedSafe NZ",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/757/original/ApoAmlodipinetab_MedSafe_NZ.pdf?1551474087
DB00395,,Carisoprodol Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/057/original/carisoprodol-soma.pdf?1553190718
DB00395,,Carisoprodol-Aspirin compound,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/060/original/Carisoprodol_Aspirin_Compound.pdf?1553196252
DB00395,,Soma compound with codeine,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/069/original/Soma_compound_with_Codeine.pdf?1553196615
DB00395,,Toxicity studies of carisoprodol: National Toxicology Program,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/078/original/Toxicity_Studies_of_Carisoprodol__National_Toxicology_Program.pdf?1553208258
DB00395,,Skeletal muscle relaxants therapeutic class review,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/093/original/Skeletal_muscle_relaxants_therapeutic_class_review.pdf?1553285461
DB00396,,Progesterone gel: Crinone® 4% and Crinone® 8%,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/898/original/Progesterone_Gel.pdf?1552088547
DB00396,,"Endometrin FDA label, vaginal insert",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/901/original/Endometrin__vaginal_insert_FDA_label.pdf?1552088774
DB00396,,Norethindrone FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/904/original/Norethindrone_FDA_label.pdf?1552320726
DB00396,,"Progesterone injection, FDA label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/907/original/Progestrone_injection__FDA_label.pdf?1552321319
DB00396,,"Utrogestan capsules, medsafe NZ label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/913/original/UtrogestanSunflowerOilcap.pdf?1552322296
DB00396,,PROGESTERONE INJECTION USP IN SESAME OIL FOR INTRAMUSCULAR USE ONLY,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/916/original/FDA_Label__Progesterone_and_sesame_oil.pdf?1552338634
DB00413,,Pramipexole hydrochloride tablets SDS,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/298/original/PRAMIPEXOLE_DIHYDROCHLORIDE_TABLETS.pdf?1554758125
DB00413,,"MedSafe NZ, Ramipex tablet information sheet",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/301/original/Ramipextab.pdf?1554758918
DB00422,,Health Canada Label - Concerta,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/474/original/Health_Canada_-_Concerta.PDF?1556049353
DB00422,,Health Canada Label - Biphentin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/480/original/Health_Canada_-_Biphentin.PDF?1556049613
DB00422,,Health Canada - Ritalin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/483/original/Health_Canada_-_Ritalin.PDF?1556050208
DB00425,,Ambien CR (extended release) label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/802/original/Aimbien_CR_%28Extended_release%29_FDA_label.pdf?1551829005
DB00432,,Lonsurf Summary of Product Characteristics- European Medicines Agency - Europa EU,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/649/original/WC500206246.pdf?1531845997
DB00432,,"DailyMed Label: VIROPTIC® Ophthalmic Solution, 1% Sterile (trifluridine ophthalmic solution)",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/658/original/20180323_f3a14d86-0ff2-4535-318c-ac8bc8ede42c.pdf?1531863617
DB00437,,"Cayman Chem MSDS, Allopurinol",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/985/original/Cayman_Chem_MSDS__Allopurinol.pdf?1552949690
DB00437,,MedSafe NZ: Allopurinol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/988/original/apoallopurinoltab.pdf?1553009459
DB00443,,Celestone Soluspan Product Insert (Injectable),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/145/original/Celestone_Soluspan_Package_Insert.pdf?1553789405
DB00451,,FDA Label - levothyroxine,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/633/original/FDA_Label_-_levothyroxine.pdf?1561401737
DB00451,,American Association of Clinical Endocrinologists (AACE): Clinical Practice Guidelines for Hypothyroidism in Adults,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/636/original/CPG_for_hypothyroidism.pdf?1561402165
DB00479,,MedSafe NZ: Amikacin Injection,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/949/original/Amikacininj._MedSafe_NZ.pdf?1540245431
DB00479,,"EMA Withdrawal document, Arikayce",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/950/original/withdrawal-assessment-report-arikayce_en.pdf?1540245524
DB00479,,"Amikacin, DailyMed",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/954/original/20180501_f260ff2a-76a0-4672-9516-91c344b67890.pdf?1540315949
DB00502,,FDA Label - haloperidol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/645/original/FDA_Label_-_haloperidol.pdf?1562874866
DB00502,,Health Canada Monograph - haloperidol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/648/original/Health_Canada_-_Haloperidol.PDF?1562879685
DB00542,,FDA Clinical Pharmacology and Biopharmaceutics Review: Lotensin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/169/original/019851s028_benazepril_Lotensin_ClinPharmReview.pdf?1553893301
DB00577,,"Valtrex tablets, MedSafe NZ",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/949/original/Valtrex_MedSafe_NZ.pdf?1552685757
DB00577,,Valacyclovir hydrochloride hydrate MSDS,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/973/original/SDS__Valacyclovir_Hydrochloride_Hydrate.pdf?1552931632
DB00582,,FDA Label VORICONAZOLE- voriconazole injection,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/036/original/20171013_63473087-5cc1-b2e8-b552-6d5f733e1227.pdf?1533833680
DB00588,,Fluticasone Propionate (Cutivate) Ointment FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/355/original/Cutivate_FDA_Label.pdf?1555083055
DB00588,,Fluticasone Propionate (Flonase) Nasal Spray FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/358/original/Flonase_FDA_Label.pdf?1555083126
DB00591,,Topical Fluocinolone acetonide,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/955/original/1.pdf?1540320566
DB00591,,Topical Fluocinolone acetonide UK label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/956/original/1.pdf?1540328065
DB00591,,Retisert (Fluocinolone acetate) FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/957/original/fda.pdf?1540331588
DB00641,,FDA Label - Simvastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/655/original/FDA_Label_-_simvastatin.pdf?1564075804
DB00641,,Health Canada Monograph - Simvastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/658/original/Health_Canada_Monograph_-_Simvastatin.PDF?1564075821
DB00668,,Epinephrine FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/247/original/Epinephrine_.pdf?1534883635
DB00668,,Primatene Prescribing Info,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/131/original/Primatene_MST_Label_Info.pdf?1543940831
DB00668,,Pfizer Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/136/original/Pfizer__Canadian_Monograph-_Epinephrine_Inj.pdf?1543958486
DB00683,,Intravenous Midazolam FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/434/original/Intraveous_Midazolam_FDA_label.pdf?1545435299
DB00683,,MedSafe NZ: Midazolam Inj,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/977/original/MedSafe_NZ.pdf?1547742953
DB00697,,"Canadian monograph, Tizanidine",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/471/original/Canadian_monograph__Tizanidine.pdf?1556041234
DB00708,,Sufentanil EMA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/009/original/zalviso-epar-product-information_en.pdf?1541442012
DB00708,,Sufentanil,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/011/original/2018_Combined-Characteristics-of-Illicit-Licit-Fentanyl-Derivatives.pdf?1541449805
DB00734,,FDA Label - Risperidone,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/697/original/FDA_Label_-_Risperidone.pdf?1568147588
DB00734,,Health Canada Monograph - Risperidone,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/700/original/Health_Canada_Monograph_-_Risperidone.PDF?1568147609
DB00736,,Health Canada Label - Esomeprazole,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/495/original/Health_Canada_Label_-_Esomeprazole.PDF?1556057784
DB00736,,TOP Guidelines - H pylori,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/498/original/h_pylori_guideline.pdf?1556058194
DB00829,,Diazepam FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/157/original/013263s094lbl.pdf?1548453858
DB00829,,Diazepam Canadian Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/160/original/Valium_PM_E.pdf?1548453895
DB00829,,"WHO Model Prescribing Information: Drugs Used in Anaesthesia, Premedication: Diazepam",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/169/original/h2929e.pdf?1548703081
DB00863,,Zantac injection FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/253/original/Zantac_Injection_FDA_label.pdf?1554480125
DB00863,,Zantac Canadian Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/280/original/Zantac_Canadian_Monograph.pdf?1554739927
DB14596,,Australian Register of Therapeutic Goods: Loteprednol etabonate Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/467/original/auspar-loteprednol-etabonate-140417-pi.docx?1536691506
DB00874,,Australian Government Department of Health Therapeutic Goods Administration OTC Medicines Monograph: Guaifenesin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/510/original/otc-medicine-monograph-guaifenesin.pdf?1556210330
DB00874,,"A NOVEL STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF GUAIPHENESIN, CHLORPHENERAMINE MALEATE & DEXTROMETHORPHAN HBr",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/516/original/46-Vol.-4-Issue-11-Nov.-2013-IJPSR-RA-2841-Paper-46.pdf?1556215987
DB00874,,National Pharmaceutical Regulatory Agency (NPRA) Guaiphenesin Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/522/original/GuaiphenesinFINAL.pdf?1556232923
DB00874,,CENTER FOR DRUG EVALUATION AND RESEARCH: CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S) OF GUAIFENESIN/HYDROCODONE BITARTRATE,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/525/original/205474Orig1s000ClinPharmR.pdf?1556298618
DB00904,,Ondansetron FDA 2016 Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/178/original/020103s035_020605s019_020781s019lbl.pdf?1548717354
DB00904,,Zofran Canadian Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/181/original/zofran_scrip_e.pdf?1548717421
DB00904,,Sandoz Ondansetron Canadian Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/184/original/Ondansetron_TAB_INJ_Monograph.pdf?1548717683
DB00945,,Durlaza FDA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/405/original/Durlaza_%28Extended_Release%29.pdf?1555433930
DB00973,,Getz Pharma: Ezita (Ezetimibe 10mg tablets) Product Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/133/original/Ezita-Tab-Leaflet-Export-GA.pdf?1528737045
DB00994,,Neomycin Opthalmic FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/634/original/20061027_cc2f489e-a75d-47dc-96d1-7f05bc6b7197.pdf?1550867334
DB00994,,Neomycin Irrigation Solution FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/637/original/20181221_a2f47d77-efd3-4c84-a364-08fb6d9978eb.pdf?1550867407
DB00994,,Neomycin Otic FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/640/original/20161020_cb105db7-ab14-4b10-8a19-58bcb5eb27cd.pdf?1550867574
DB00994,,Neomycin Tablet FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/643/original/20181130_777dbfab-f83e-4738-ae1e-78619a9f82a7.pdf?1550867592
DB01001,,Salbutamol Australian Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/265/original/ventolin_cfc_free_inhaler_pi_004_approved.pdf?1548976568
DB01001,,Salbutamol Canadian Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/268/original/ventolin-hfa.pdf?1548976627
DB01043,,Alzheimer's disease international: Global Impact of Dementia 2013,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/366/original/GlobalImpactDementia2013.pdf?1555345885
DB01043,,Memantine Product,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/375/original/Memantine_FCT_PM_English20150916.pdf?1555348927
DB01049,,Pharmacopeia,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/042/original/Codergocrine-Mesilate.pdf?1525473823
DB01068,,Rivotril (Clonazepam) 0.5 mg and 2 mg Tablets Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/763/original/Rivotril_PM_E.pdf?1551482154
DB01068,,Clonazepam Fact Sheet from http://cdn.neiglobal.com/content/pg/live/clonazepam.pdf,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/787/original/clonazepam.pdf?1551739786
DB01068,,Rivotril (Clonazepam) Australian Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/796/original/pdf.pdf?1551808286
DB01075,,"Diphenhydramine Hydrochloride Injection, USP FDA Label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/352/original/091526lbl.pdf?1549410675
DB01075,,"DIPHENHYDRAMINE- diphenhydramine hcl tablet, coated DailyMed FDA Label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/379/original/20180620_70a584ab-9e24-404a-aad7-f9a05c377248.pdf?1549478576
DB01075,,Benylin Chesty Coughs UK MHRA Product Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/394/original/con1478238522475.pdf?1549496792
DB01076,,FDA Label - Atorvastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/670/original/FDA_Label_-_atorvastatin.pdf?1565199067
DB01076,,Health Canada Monograph - Atorvastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/673/original/Health_Canada_Monograph_-_Atorvastatin.PDF?1565199092
DB01079,,Tegaserod 2019 FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/223/original/021200Orig1s015lbl.pdf?1554242756
DB01079,,EMA Refusal Assessment Report for Zelnorm (Tegaserod),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/226/original/zelnorm-epar-refusal-public-assessment-report_en.pdf?1554245227
DB01079,,FDA Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Briefing Document for Zelnorm (tegaserod maleate),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/229/original/GIDAC-10172018-SloanBackgrounder.pdf?1554245700
DB01087,,CYP1A2 CTEP document,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/704/original/cyp1a2.doc?1538174292
DB01098,,FDA Label - Rosuvastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/649/original/FDA_Label_-_Rosuvastatin.pdf?1563989473
DB01098,,Health Canada Monograph - Rosuvastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/652/original/Health_Canada_Label_-_Rosuvastatin.PDF?1563989610
DB01156,,The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/624/original/CANMAT_Comorbidity_Mood-Disorders-and-ADHD-20121.pdf?1558035212
DB01220,,Rifaximin Australian Public Assessment Report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/751/original/auspar-rifaximin-121119.pdf?1538670610
DB01235,,Sinemet FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/579/original/Sinemet_FDA_Label.pdf?1556654841
DB01277,,Mecasermin Highlights of Prescribing Information Revised February 2010,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/009/original/021839s016lbl.pdf?1553026301
DB01277,,European Patent Specification,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/036/original/EP1183042B1.pdf?1553113503
DB01452,,Morphine Sulfate FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/857/original/022207s004lbl.pdf?1547230559
DB03088,,Cosmetic Ingredient Review: Safety Assessment of PCA and Its Salts as Used in Cosmetics,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/053/original/pca.pdf?1525819497
DB03766,,Compendium of Pharmaceutical Excipients for Vaginal Formulations,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/050/original/article-5133.pdf?1525799351
DB04896,,Fetzima (levomilnacipran extended-release capsules) Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/919/original/fetzima-monograph.pdf?1552429131
DB04896,,Fetzima (levomilnacipran) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/922/original/Fetzima-final_labeling_text_CLEAN_12_2017.pdf?1552429193
DB04896,,Savella (milnacipran HCl) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/925/original/022256s022lbl.pdf?1552429243
DB04896,,Australian Public Assessment Report for Milnacipran hydrochloride,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/928/original/auspar-milnacipran-hydrochloride-120124.pdf?1552429553
DB04896,,EMEA REFUSAL ASSESSMENT REPORT FOR Milnacipran Pierre Fabre Medicament,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/934/original/milnacipran-pierre-fabre-medicament-epar-refusal-public-assessment-report_en.pdf?1552430406
DB04896,,"Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) by Ipek Komsuoglu Celikyurt, Oguz Mutlu, and Guner Ulak",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/937/original/InTech-Serotonin_noradrenaline_reuptake_inhibitors_snris_.pdf?1552594580
DB05018,,Patent US20180208955A1: Process for the microbial synthesis of migalastat,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/104/original/US20180208955A1.pdf?1534266673
DB05242,,Nucleonics NUC B1000 Press Release,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/910/original/Start_of_Hep_B_Trial_-_011108.pdf?1552322229
DB06081,,Cablivi (caplacizumab) EMA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/457/original/1.pdf?1549670242
DB06210,,Eltrombopag,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/655/original/Eltrombopag_FDA_label.pdf?1537903177
DB06219,,Dalbavacin Health Canada Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/356/original/00047194.PDF?1545155127
DB06219,,Dalbavancin EMA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/380/original/anx_136966_en.pdf?1545238693
DB06480,,Resotrans (prucalopride) Australian label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/384/original/1.pdf?1545258246
DB06480,,Resotrans (prucalopride) Australian data sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/386/original/1.pdf?1545259268
DB06695,,Apotex Inc. Product Monograph: Dabigatran Etexilate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/423/original/Apotex_Inc_Product_Monograph_Dabigatran_Etexilate.PDF?1555955264
DB06701,,Focalin (Dexmethylphenidate) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/390/original/Focalin_Label.pdf?1555362054
DB06701,,Dexmethylphenidate XR FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/393/original/Dexmethylphenidate_XR_Label.pdf?1555362204
DB06711,,New Zealand Data Sheet: Naphcon-A Eye Drops,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/214/original/naphconAeyedrop.pdf?1554234294
DB08860,,FDA Label - Pitavastatin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/667/original/FDA_Label_-_Pitavastatin.pdf?1564609735
DB08867,,European Medicines Agency CHMP Assessment Report for Ellaone (ulipristal acetate),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/769/original/ellaone-epar-public-assessment-report_en.pdf?1551721932
DB08867,,ella (ulipristal acetate) 30 mg Tablet Emergency Contraceptive Canadian Product Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/772/original/00035187.PDF?1551722292
DB08904,,CIMZIA (Certolizumab) Australian Report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/232/original/auspar-cimzia.pdf?1554327113
DB08906,,Fluticasone Furoate (Arnuity Ellipta) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/364/original/Arnuity_Ellipta_FDA_Label.pdf?1555084343
DB08907,,"Invokana, Canadian monograph",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/313/original/Invokana__Canadian_monograph.pdf?1554913610
DB08912,,NZ DrugSafe Tafinlar,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/051/original/tafinlarnz.pdf?1525808860
DB08912,,"Monograph, Tafinlar",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/052/original/tafinlar_scrip_e.pdf?1525814014
DB09037,,Keytruda monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/136/original/1.pdf?1528923198
DB09037,,Keytruda official monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/137/original/1.pdf?1528923784
DB09054,,FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/494/original/Idelalisib.pdf?1536961865
DB09073,,IBRANCE (palbociclib) BC Cancer monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/265/original/1.pdf?1554501162
DB09141,,"Protamine Sulfate Injection, USP Product Information",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/559/original/Protamine_Sulfate-PI-eng-v1.1-Clean.pdf?1550619645
DB09141,,UKPAR MHRA Prosulf (protamine sulphate) 10mg/ml Solution for Injection Assessment,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/562/original/con272229.pdf?1550683924
DB09268,,FDA Clinical Pharmacology and Biopharmaceutical Review(s) on PICOPREP,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/135/original/202535Orig1s000ClinPharmR.pdf?1528755368
DB09289,,The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural-associational synapse in chronically stressed rats,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/134/original/tianeptinedoc.pdf?1528746183
DB09302,,Alirocumab FDA Label 2019,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/591/original/125559s019s020lbl.pdf?1556731499
DB11060,,European Food Safety Document,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/097/original/polyvinuyl_alcohol.pdf?1527017890
DB11085,,Resorcinol - Wiley Online Library Resource,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/061/original/3527600418.mb10846e0020.pdf?1526059762
DB11085,,TUKES Finnish Safety and Chemicals Agency: Evaluation Report for Resorcinol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/062/original/SEV-203-585-2-1_conclusion_and_report_public_5148_en.pdf?1526062531
DB11110,,Magnesium citrate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/099/original/1.pdf?1527098397
DB11112,,Safety Assessment of Polyether Lanolins as Used in Cosmetics,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/015/original/PolLan062012Tent.pdf?1525110302
DB11113,,"Assessment report on Ricinus communis L., oleum - European Medical Agency",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/070/original/WC500190197.pdf?1526416724
DB11113,,European Commission: Review of Annex IV of Regulation (EC) No. 1907/2006 (REACH),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/075/original/6b_appendix_2.pdf?1526488081
DB11113,,NATIONAL TOXICOLOGY PROGRAM: NTP Technical Report on the Toxicity Studies of Castor Oil in F344/N Rats and B6C3F1 Mice (Dose Feed Studies),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/076/original/tox012.pdf?1526488449
DB11155,,Triclocarban [CASRN 101-20-2],//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/041/original/052410Triclocarban.pdf?1525466991
DB11185,,"Health Canada Monograph, Sunscreens",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/038/original/mono_sunscreen-monograph_english.pdf?1525453011
DB11185,,NTP Technical Report on the Toxicity Studies of Benzophenone,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/040/original/benophenones_NIH_tox.pdf?1525463001
DB11198,,Cosmetic Ingredient Review: Amended Safety Assessment of Mentha Piperita (Peppermint)-derived Ingredients as Used in Cosmetics,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/077/original/peppermint.pdf?1526491660
DB11198,,European Medicines Agency (EMA) COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC): Final Community herbal monograph on Mentha x piperita L Aetheroleum,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/078/original/WC500059313.pdf?1526491780
DB11200,,Scientific Committee on Consumer Safety SCCS,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/048/original/22029_methyl_salicylate_clinical2_prea.pdf?1525732838
DB11200,,ZIRKONAL® L435G,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/049/original/ZIR-L435G.pdf?1525793548
DB11201,,Drug Insert,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/091/original/Menthol_Camphor_Methylsalicylate_Ointment_or_Liniment_or_Cream%282%29.pdf?1526682686
DB11202,,United States Patent Office: Synergistic Blends of Microbiocidal Quaternary Ammonium Compounds,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/109/original/US3472939.pdf?1527191203
DB11202,,Quaternary Ammonium Compounds in Cleaning Products: Health & Safety Information for Health Professionals,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/110/original/QACs_Info_for_Physicians_18.pdf?1527191270
DB11207,,Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and In Vitro Methods,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/035/original/cosmetics-05-00001.pdf?1525449150
DB11217,,Chemical Information Review Document for Arbutin [CAS No. 497-76-7] for Arbutin and Extracts from Arctostaphylos uva-ursi,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/043/original/arbutin_508.pdf?1525474930
DB11217,,European Commission Scientific Committee on Consumer Products (SCCP): Opinion on beta-arbutin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/044/original/sccp_o_134.pdf?1525712439
DB11219,,OPINION ON 4-Methylbenzylidene camphor (4-MBC) - European Union,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/039/original/sccp_o_075.pdf?1525453589
DB11226,,NATIONAL INDUSTRIAL CHEMICALS NOTIFICATION AND ASSESSMENT SCHEME (NICNAS) Public Report On: Ethylhexyl Methoxycrylene,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/101/original/STD-1444-FR_Final.docx?1527109345
DB11226,,Sunscreen Photostability 101,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/103/original/SunscreenPhotostability101.pdf?1527110179
DB11226,,Hallstar Sun Care Advanced Formulated Solutions Brochure,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/104/original/Hallstar_Sun_Care_Brochure_2017.pdf?1527110241
DB11254,,Health Products Regulatory Authority of Ireland: Summary of Product Characteristics for Hexylresorcinol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/057/original/LicenseSPC_PA0979-042-001_08122016162037.pdf?1525986082
DB11254,,University of Utah College of Pharmacy: Topical Analgesic and Anaesthetic Agents Drug Class Review,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/058/original/Topical_Analgesics_and_Anesthetics_Drug_Class_Review.pdf?1525986844
DB11262,,"European Commission Scientific Committee on Consumer Safety (SCCS): Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3- tetramethylbutyl)phenol)",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/090/original/sccs_o_129.pdf?1526598328
DB11265,,"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710
DB11269,,European Commission: OPINION ON Diethylamino hydroxybenzoyl hexyl benzoate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/107/original/sccp_o_130.pdf?1527182624
DB11271,,Parsol SLX Product Brochure,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/087/original/SUB8_DSM_PARSOL_SLX.pdf?1526595708
DB11271,,Parsol SLX: UV Protection by Liquid-Mineral Technology,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/088/original/DSM_ParsolSLX.pdf?1526595755
DB11271,,European Commission Directorate-General for Health & Consumers: Scientific Committee on Consumer Safety Opinion On Polysilicone-15,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/089/original/sccs_o_024.pdf?1526596205
DB11278,,Revision of Precautions Dihydrocodeine phosphate/ dl-Methylephedrine hydrochloride/ Chlorpheniramine maleate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/098/original/Ministry_of_Health_Japan.pdf?1527095544
DB11278,,"4-Methylephedrine, EUA",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/100/original/4-Methylephedrine.docx?1527105098
DB11323,,Clinical Review: CLINICAL REVIEW,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/045/original/22029_methyl_salicylate_clinical2_prea.pdf?1525721199
DB11324,,EMA summary report Nonivamide,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/031/original/WC500015186EMANonivamide.pdf?1525300972
DB11338,,"Clove oil, FDA Document",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/102/original/GFI__150_Clove_Oil.pdf?1527110031
DB11338,,Chapter 6- Eugenol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/108/original/Eugenol.pdf?1527189892
DB11358,,Gamma-linolenic acid monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/105/original/1.pdf?1527111020
DB11358,,Chemical Information Document of the National Toxicology Program,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/111/original/1.pdf?1527196128
DB11431,,EMA reports,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/139/original/1.pdf?1529099329
DB11482,,FDA approved allergenic test,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/117/original/1.pdf?1527270693
DB11482,,EMA Assessment Report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/121/original/1.pdf?1527283350
DB11581,,Australian Product Information: Venetoclax,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/124/original/Product_information__Australia__for_Venetoclax.pdf?1543868641
DB11581,,"Venetoclax, Previous FDA label",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/130/original/Venetoclax_old.pdf?1543878328
DB11583,,Bonjela monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/092/original/1.pdf?1526683267
DB11585,,Health Canada: Sunscreen Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/081/original/mono_sunscreen-monograph_english.pdf?1526509142
DB11585,,FDA Drometrizole Trisiloxane Safety Assessment Denial Letter,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/082/original/140908_FDA_sunscreen_denial_letter.pdf?1526509260
DB11587,,Etafedrine Hydrochloride,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/006/original/Etafedrine.pdf?1524858118
DB11588,,The carbon monoxide diffusing capacity,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/004/original/PIIS0012369208602743.pdf?1524847041
DB11588,,2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/005/original/DLCO.pdf?1524848064
DB11640,,FIRDAPSE (amifampridine) SUMMARY OF PRODUCT CHARACTERISTICS (EMA Label),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/272/original/WC500069915.pdf?1530026934
DB11640,,European Medicines Agency (EMA) Assessment Report for Zenas (INN-amifampridine),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/273/original/WC500069918.pdf?1530028128
DB11640,,RUZURGI (amifampridine) 2019 US FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/609/original/209321s000lbl.pdf?1557506341
DB11672,,"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710
DB11718,,Encorafenib review,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666
DB11735,,Lactulose Solution USP Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/030/original/lactulose.pdf?1525284237
DB11823,,"Janssen slides, esketamine",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/805/original/PDAC_DSaRM-2122019-JanssenSlides.pdf?1551892129
DB11859,,NHS Evidence Briefing January 2019: Brexanolone for postpartum depression,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/063/original/10557-Brexanolone-for-postpartum-depression-V1.0-JAN2019-NONCONF.pdf?1553196439
DB11859,,FDA approves first treatment for post-partum depression: Press Release,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/066/original/Press_Announcements___FDA_approves_first_treatment_for_post-partum_depression.pdf?1553196545
DB11859,,"FDA Briefing Document: New Drug Application 211371/New Drug Application, brexanolone for the Treatment of Postpartum Depression",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/072/original/PDAC_DSaRM-11022018-FDABackgrounder.pdf?1553196664
DB11859,,Clonazepam Fact Sheet from http://cdn.neiglobal.com/content/pg/live/clonazepam.pdf,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/787/original/clonazepam.pdf?1551739786
DB11963,,Pfizer Oncology Dacomitinib (PF-00299804) Fact Sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/005/original/dacomitinib_fact_sheet.pdf?1541191335
DB11967,,Binimetinib,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/363/original/binimetinib_MSDS.pdf?1530650348
DB11967,,EMA assessment,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/368/original/EMA_withdrawal_letter.pdf?1530653382
DB11978,,Pfizer Glasdegib product information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/971/original/msds.pdf?1547590283
DB11979,,U.S. Department of Health and Human Services (2002): Endometriosis,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/801/original/endometriosis-2002.pdf?1532543167
DB11979,,AbbVie Orilissa (elagolix) FDA Approval Press Release,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/815/original/AbbVie_Receives_U.S._FDA_Approval_of_ORILISSA%E2%84%A2_%28elagolix%29_for_the_Management_of_Moderate_to_Severe_Pain_Associated_with_Endometriosis.pdf?1532619040
DB11995,,"NICE UK review document, Avatrombopag",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/095/original/avatrombopag-thrombocytopenia-draft-scope.pdf?1527011866
DB12147,,Cayman Chemical Erdafitinib MSDS,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/369/original/21813m.pdf?1555347445
DB12147,,NHS Evidence Briefing On: Erdafitinib capsules for metastatic or surgically unresectable urothelial cancer with FGFR gene aberrations – second line therapy,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/372/original/11254-Erdafitinib-for-Urothelial-Cancer.pdf?1555347590
DB12328,,Canthacur (cantharidin 0.7%) Solution for Topical Use Package Insert,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/032/original/Canthacur_Insert_En.pdf?1525365901
DB12783,,Roche Canada Product Monograph: Prolopa,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/002/original/Prolopa_PM_E.pdf?1524844057
DB12783,,European Medicines Agency Public Summary of Opinion on Orphan Designation: Benserazide Hydrochloride for the Treatment of Beta Thalassaemia Intermedia and Major,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/003/original/WC500183229.pdf?1524846665
DB12783,,AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/007/original/AGNP_Consensus_Guidelines_for_Therapeutic_Drug.pdf?1524860933
DB12836,,Galliprant (Grapiprant) FDA veterinary label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/060/original/20180605_a38cc5c6-93e8-4c90-aabc-33bc8423beab.pdf?1542915905
DB12836,,Galliprant (Grapiprant) EMA veterinary label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/061/original/1.pdf?1542923080
DB12911,,Finalgon Cream (nonivamide and butoxyethyl nicotinate) Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/011/original/FINALGON-PI.pdf?1525102181
DB12911,,European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit: Committee for Veterinary Medicinal Products Nicoboxil Summary Report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/012/original/WC500015180.pdf?1525102332
DB12911,,"Bundesinstitut fur Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report: Finalgon 4 mg/g + 25 mg/g Salbe Nonivamide, Nicoboxil",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/016/original/DE_H_3291_001_PAR.pdf?1525110423
DB13178,,Inositol report University of Wisconsin,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/017/original/1.pdf?1525111342
DB13231,,GRAS Notification for the Use of Calcium Lactate in Potato and Vegetable Snacks and Sweetened Crackers,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/059/original/GRN747-web.pdf?1526058884
DB13235,,Technical data sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/066/original/1.pdf?1526406716
DB13235,,OECD SIDS,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/067/original/1.pdf?1526407365
DB13249,,Lecture,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/026/original/1.pdf?1525204578
DB13269,,Strepsils,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/071/original/1.pdf?1526422603
DB13269,,Netherlands Public Assessment Report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/072/original/1.pdf?1526423670
DB13269,,Product characteristics throat lonzenges,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/073/original/1.pdf?1526424270
DB13269,,Strepsils + anaesthetic spray,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/074/original/1.pdf?1526425350
DB13306,,Sterosan Marketing Article,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/549/original/Prescription_Pad_Sterosan_Marketing.pdf?1556641498
DB13306,,EMA Approved Product List Chlorquinaldol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/552/original/EMA_Approvals_for_Chlorquinaldol.pdf?1556641531
DB13444,,Health Canada label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/054/original/1.pdf?1525900564
DB13444,,Telebrix Gastro monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/055/original/1.pdf?1525902201
DB13444,,Telebrix summary of product,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/056/original/1.pdf?1525905430
DB13518,,Gaviscon Summary of Product Characteristics,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/046/original/LicenseSPC_PA0979-015-001_21022014152038.pdf?1525723709
DB13595,,"University of Ottawa, Interdisciplinary Journal of Health Sciences: Human Health Effects of Dietary Aluminum",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/023/original/227-26-PB.pdf?1525197968
DB13595,,Healthy Canadians: Water Aluminum,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/024/original/water-aluminum-eau-eng.pdf?1525198004
DB13595,,"Package Leaflet: Information for the patient, Megalac Almasilate 1 g /10 mL Suspension",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/025/original/Megalac-Almasilat_EN.pdf?1525198124
DB13707,,KARL FISCHER ELECTROMETRIC TITRATION METHOD FOR DETERMINATION OF WATER CONTENT,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/018/original/Karlfischer.pdf?1525123760
DB13749,,Safety Data,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/019/original/3632-91-5_%28USA%29fargon.pdf?1525126939
DB13751,,FDA records,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/079/original/1.pdf?1526493192
DB13751,,FDA food aditives,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/080/original/1.pdf?1526494163
DB13800,,Chemical Research in Toxicology: Levulinate - Potentially Toxic Pro-Drug of Abuse,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/068/original/tx4000039.pdf?1526414150
DB13800,,Clinical Laboratory Tests Reference Values (from http://www.royalcollege.ca/rcsite/documents/credential-exams/clinical-lab-tests-reference-values-e.pdf),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/069/original/clinical-lab-tests-reference-values-e.pdf?1526416461
DB13854,,Gamma-Linolenic Acid (GLA) Monograph - Semantic Scholar,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/027/original/496215cecef1f527d4787e065f20ccf1e3fe.pdf?1525205244
DB13867,,Fluticasone Propionate (Cutivate) Ointment FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/355/original/Cutivate_FDA_Label.pdf?1555083055
DB13867,,Fluticasone Propionate (Flonase) Nasal Spray FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/358/original/Flonase_FDA_Label.pdf?1555083126
DB13867,,Fluticasone Furoate (Veramyst) Nasal Spray FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/361/original/Veramyst_FDA_Label.pdf?1555084174
DB13867,,Fluticasone Furoate (Arnuity Ellipta) FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/364/original/Arnuity_Ellipta_FDA_Label.pdf?1555084343
DB13882,,The European Agency Committee for Veterinary Medicinal Products: Methyl Nicotinate Summary Report,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/063/original/WC500015074.pdf?1526077961
DB13882,,Norwegian Food Safety Authority (Mattilsynet): Methyl Nicotinate (MN) Risk Profile,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/064/original/Risk_Profile_Methyl_Nicotinate.pdf?1526078027
DB13882,,Prostaglandins and nicotine-provoked increase in cutaneous blood flow,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/065/original/0d66273417ccef33671044bf478936e65155.pdf?1526078204
DB13892,,Crotalus atrox PhospholipaseAz,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/112/original/J._Biol._Chem.-1982-Randolph-2155-61.pdf?1527201766
DB13892,,Crotalidae Polyvalent Immune Fab (Ovine),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/113/original/Crotalidae_Polyvalent_Immune_Fab_%28Ovine%29_%28PDF_Download_Available%29.pdf?1527201938
DB13893,,"Crotalidae Polyvalent, Ovine",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/116/original/Crotalidae_Polyvalent_Immune_Fab_%28Ovine%29_%28PDF_Download_Available%29.pdf?1527270528
DB13893,,Amino Acid Sequence of Phospholipase AZ-a! from the Venom of Crotalus adamanteus,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/119/original/J._Biol._Chem.-1977-Heinrikson-4913-21.pdf?1527281760
DB13894,,THE PHOSPHOLIPASE OF THE VENOM OF THE COTTONMOUTH SNAKE,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/122/original/PiscJ._Biol._Chem.-1945-Fairbairn-633-44.pdf?1527284721
DB13894,,"U Tox update, UTAH document",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/123/original/UTAH_tox_update.pdf?1527287976
DB13908,,"PUBLIC ASSESSMENT REPORT of the Medicines Evaluation Board in the Netherlands: Amylmetacresol and 2,4-Dichlorobenzyl alcohol",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/008/original/netherlandreport.pdf?1524863750
DB13908,,UK public assessment report: Sore Throat Relief Honey & Lemon Flavour 0.6mg Lozenges,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/009/original/UKpublicassess.pdf?1524863909
DB13908,,Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges.,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/010/original/j.1742-1241.2011.02644.x.pdf?1524864319
DB13923,,Hemlibra (Emicizumab) EMA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/947/original/1.pdf?1540241108
DB13944,,XYOSTED Subcutaneous Testosterone Enanthate Injection FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/941/original/209863s000lbl.pdf?1539982958
DB13960,,United States Environmental Protection Agency (EPA): Bronopol R.E.D. Facts Sheet,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/013/original/fs_PC-216400_1-Oct-95.pdf?1525106735
DB13960,,"The activity and safety of the antimicrobial agent Bronopol (2-bromo-2-nitropropan-1, 3-diol)",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/014/original/10.1.1.562.6397.pdf?1525109761
DB13960,,Canadian Pest Management Regulatory Agency Re-evaluation of Bronopol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/317/original/H113-18-2005-6E.pdf?1545069110
DB13961,,Australian Government Department of Health and Ageing Therapeutic Goods Administration: Australian Public Assessment Report for Omega-3-acid ethyl esters 90,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/033/original/auspar-omacor.pdf?1525448587
DB13961,,Smoflipid FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/034/original/207648lbl.pdf?1525448851
DB13961,,Lovaza FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/036/original/021654s041lbl.pdf?1525449483
DB13961,,Omacor (omega-3-fatty ethyl esters) EMA Prescribing Information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/037/original/21654lbl.pdf?1525452399
DB13961,,CENTER FOR DRUG EVALUATION AND RESEARCH PHARMACOLOGY REVIEW OF EPANOVA,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/250/original/205060Orig1s000PharmR.pdf?1554408769
DB13964,,Cerumol,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/124/original/1.pdf?1527288141
DB13964,,Emolients,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/125/original/Emollient_Product_List_June_2013_CV.pdf?1527289102
DB13987,,INCHEM Strontium and strontium compounds Profile,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/118/original/cicad77.pdf?1527279885
DB14001,,EMEA CHMP Assessment Report for Vedrop (polymeric mixture consisting of esterification of d- alpha tocopherol succinate with polyethylene glycol 1000 (PEG)),//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/047/original/WC500047922.pdf?1525727854
DB14019,,EMA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/029/original/EMAnet.pdf?1525278584
DB14040,,"Presentation on CGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS)",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/094/original/Diener-Hans-Christoph_CGRP-M.pdf?1527011193
DB14041,,"Presentation on CGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS)",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/094/original/Diener-Hans-Christoph_CGRP-M.pdf?1527011193
DB14048,,EMA Sodium Zirconium Cyclosilicate Monograph,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/130/original/WC500246774.pdf?1528233036
DB14074,,Health Canada Icaridin Evaluation,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/692/original/H113-9-2011-10-eng.pdf?1538088454
DB14185,,ABILIFY (aripiprazole)Tablets FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/397/original/021713s004_021436s007lbl.pdf?1530736008
DB14512,,Mometasone Furoate Nasonex FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/292/original/Mometasone_Furoate_Nasonex_Label.pdf?1554757783
DB14512,,Mometasone Furoate Elocon FDA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/295/original/Mometasone_Furoate_Elocon_Label.pdf?1554757811
DB14597,,WHO sequence of lanadelumab,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/468/original/1.pdf?1536692138
DB14700,,World Health Organization Document,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/604/original/World_Health_Organization_Document.pdf?1537477481
DB14700,,Extended Half-Life Factor VIII and Factor IX Preparations,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/607/original/Damoctagol_.pdf?1537480155
DB14700,,"BLA, Damoctacog alfa peg, August 2018",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/609/original/August_29__2018_SBRA_-_JIVI.pdf?1537545259
DB14712,,NIHS reports,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/937/original/1.pdf?1539979813
DB14712,,WHO Drug Information 2017,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/939/original/1.pdf?1539981000
DB14712,,Revcovi information,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/940/original/1.pdf?1539981189
DB14713,,Tegsedi EMA label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/001/938/original/tegsedi-epar-product-information_en.pdf?1539980614
DB14730,,Medsafe NZ: Erwinaze inj,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/432/original/Erwinaseinjm_Medsafe_NZ.pdf?1545430492
DB14738,,"Novo Nordisk receives US FDA approval of ESPEROCT® (turoctocog alfa pegol, N8-GP) Press Release",//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/649/original/2235689.pdf?1550875461
DB14738,,Turoctocog alfa EMA Label,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/685/original/novoeight-epar-product-information_en.pdf?1551138300
DB14738,,PeerView CME: Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/703/original/PVI_monograph_VEQ.pdf?1551211474
DB00781,,Product Monograph: Polymyxin B For Injection USP,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/151/original/1.3.1-SteriMax-English-PM-February-8-201612.pdf?1553794616
DB14751,,European Medicines Agency Withdrawal Assessment Report For Mecasermin Rinfabate,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/054/original/withdrawal-assessment-report-iplex_en.pdf?1553187337
DB14751,,Withdrawal Of Application For Mecasermin Rinfabate Marketing Authorization With European Medicines Agency,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/075/original/withdrawal-letter-iplex_en.pdf?1553198320
DB15066,,Supplementary Appendix for Phase 1 trial of an RNA interference therapy for acute intermittent porphyria,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/724/original/supplement_to_30726693.pdf?1574362854
DB15066,,Study Protocol for Phase 1 trial of an RNA interference therapy for acute intermittent porphyria,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/727/original/protocol_for_phase_1_trial.pdf?1574375964
DB16443,,National Health Commission of the People's Republic of China: COVID-19 vaccine candidate produced from insect cells to enter human trials,//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/738/original/National_Health_Commission_of_the_People's_Republic_of_China-_COVID-19_vaccine_candidate_produced_from_insect_cells_to_enter_human_trials.pdf?1610986014
